Gilead inks $5B upfront deal to gain broad access to Galapagos’ pipelineAllbiopro2019-07-16T09:02:18+09:007월 16th, 2019|
Boehringer buys up cancer vaccine player, eyes oncology combo strategyAllbiopro2019-07-16T09:01:45+09:007월 16th, 2019|
J&J gears up for clinical test of HIV vaccine efficacyAllbiopro2019-07-16T09:01:12+09:007월 16th, 2019|
Could Karyopharm’s newly approved multiple myeloma drug also work in glioblastoma?Allbiopro2019-07-16T09:00:41+09:007월 16th, 2019|
Eton Pharma dips as FDA rejects its Bausch-partnered conjunctivitis medAllbiopro2019-07-16T09:00:07+09:007월 16th, 2019|
Gilead and Galapagos Enter Into Transformative Research and Development CollaborationAllbiopro2019-07-16T08:59:35+09:007월 16th, 2019|
Kaneka launches a takeover bid for 100% of spanish biotechnology company AB-BioticsAllbiopro2019-07-16T08:58:34+09:007월 16th, 2019|
Invitae to Acquire Jungla to Advance Genetic Variant Interpretation, Adds Supplemental RNA Analysis to Deliver Deeper, More Informative Results to PatientsAllbiopro2019-07-12T09:57:32+09:007월 12th, 2019|
Toluna Partners with NeoCurrency to Offer Cryptocurrency Rewards to Toluna InfluencersAllbiopro2019-07-12T09:56:59+09:007월 12th, 2019|
HealthTree® Patient Portal Surpasses 4,200 Users Representing 4% of All Multiple Myeloma Patients in the U.S.Allbiopro2019-07-12T09:56:30+09:007월 12th, 2019|
Parks Associates: 22% of US consumers Used a Self-Diagnosis App in Past 12 MonthsAllbiopro2019-07-12T09:55:59+09:007월 12th, 2019|
Report: HCI Boosts Diagnostic Imaging Departments ConversionsAllbiopro2019-07-12T09:55:27+09:007월 12th, 2019|
Keystone Heart Ltd. and Vasorum Ltd. enter distribution agreement for Celt ACD® Vascular Closure DeviceAllbiopro2019-07-12T09:54:58+09:007월 12th, 2019|
